Searchable abstracts of presentations at key conferences in endocrinology

ea0050p386 | Thyroid | SFEBES2017

Prevalence of and factors predicting thyroid dysfunction at the time of ST- and non-ST- elevation myocardial infarction – the ThyrAMI 1 study

Jabbar Avais , Ingoe Lorna , Zaman Azfar , Razvi Salman

Introduction: Thyroid dysfunction is common affecting 5–10% of the adult population. Cardiovascular disease, including acute myocardial infarction (AMI), has been suggested as one of the adverse outcomes of thyroid disease. Furthermore, individuals with thyroid dysfunction at the time of AMI have worse outcomes. Despite this, there is scarce data on the prevalence of thyroid dysfunction in patients with AMI. We conducted a prospective observational multi-cen...

ea0050p392 | Thyroid | SFEBES2017

The relationship between free T4 and thyrotropin receptor antibodies is log-linear and negatively influenced by age and smoking in patients with Graves’ disease

Gan Earn H , Tsatlidis Vasileios , Kennedy David , Razvi Salman

Background: The third generation thyrotropin receptor antibodies (TRAb) assay has high sensitivity and specificity in diagnosing Graves’ disease (GD). Circulating levels of TRAbs predict the disease course of Graves’ orbitopathy (GO) and remission rates in GD. However, the relationship between TRAb and thyroxine (FT4) and the factors affecting their interaction are unclear.Method: A prospective cohort study was conducted to evalua...

ea0050p386 | Thyroid | SFEBES2017

Prevalence of and factors predicting thyroid dysfunction at the time of ST- and non-ST- elevation myocardial infarction – the ThyrAMI 1 study

Jabbar Avais , Ingoe Lorna , Zaman Azfar , Razvi Salman

Introduction: Thyroid dysfunction is common affecting 5–10% of the adult population. Cardiovascular disease, including acute myocardial infarction (AMI), has been suggested as one of the adverse outcomes of thyroid disease. Furthermore, individuals with thyroid dysfunction at the time of AMI have worse outcomes. Despite this, there is scarce data on the prevalence of thyroid dysfunction in patients with AMI. We conducted a prospective observational multi-cen...

ea0050p392 | Thyroid | SFEBES2017

The relationship between free T4 and thyrotropin receptor antibodies is log-linear and negatively influenced by age and smoking in patients with Graves’ disease

Gan Earn H , Tsatlidis Vasileios , Kennedy David , Razvi Salman

Background: The third generation thyrotropin receptor antibodies (TRAb) assay has high sensitivity and specificity in diagnosing Graves’ disease (GD). Circulating levels of TRAbs predict the disease course of Graves’ orbitopathy (GO) and remission rates in GD. However, the relationship between TRAb and thyroxine (FT4) and the factors affecting their interaction are unclear.Method: A prospective cohort study was conducted to evalua...

ea0086oc6.6 | Thyroid | SFEBES2022

Can systemic cytokines predict relapse of graves’ disease?

Lane Laura , Jash Simran , Cheetham Tim , Razvi Salman , Pearce Simon

Background and Aims: Relapse in Graves’ disease (GD) often occurs after antithyroid drugs (ATD) are withdrawn, however there is a lack of robust predictive biomarkers for relapse and little mechanistic insight into its pathophysiology. B-cell related cytokines and chemokines may reflect humoral immune activity and therefore be predictive of outcome. The purpose of this study was to evaluate serum B-cell activating factor (BAFF), Chemokine ligand 13 (CXCL13), A-proliferati...

ea0044p257 | Thyroid | SFEBES2016

Vitamin D supplementation in Graves’ disease and risk of relapse

Ashraff Suhel , Addison Caroline , Tsatlidis Vasilieos , Razvi Salman

Background: Graves’ disease (GD) is an auto-immune condition where the thyroid gland produces excess hormones due to stimulation of the TSH receptor. Treatments for GD have largely remained unchanged for over 60 years. The commonest treatment strategy is to use anti-thyroid drugs (ATD) which has limited efficacy and may have serious side-effects. Newer therapies are required that will supplement existing therapies and impact on the underlying immune mechanisms of GD. Vita...

ea0038p435 | Thyroid | SFEBES2015

The natural history of subclinical hyperthyroidism due to Graves’ disease

Zhyzhneuskaya Sviatlana , Addison Caroline , Weaver Jola , Tsatlidis Vasileios , Razvi Salman

Background: There is little information regarding the natural history of subclinical hyperthyroidism (SH) due to Graves’ disease (GD). The objectives of this study were to assess the natural course of individuals with SH due to GD over a prolonged period. We also investigated the factors contributing to the progression or remission in these patients.Methods: A prospective analysis of patients with SH due to GD between 2007 and 2013 who had at least ...

ea0028oc3.7 | Obesity, thyroid and Addison's disease | SFEBES2012

Subclinical hypothyroidism is associated with fatigue and impaired functional status in males in the Whickham 20-year follow up cohort

Madathil Asgar , Razvi Salman , Vanderpump Mark , Pearce Simon , Weaver Jolanta

Introduction: The association between fatigue, functional status and subclinical hypothyroidism (SCH) remains unclear. The available data is not consistent, and this is likely to be due to selection bias in studies recruiting patients from clinic rather than unselected community populations. Only population surveys looking at prevalence of fatigue and functional status in SCH are likely to provide the answer.Objective and Methodology: We compared the pre...

ea0015p378 | Thyroid | SFEBES2008

Specificity of first-line tests for the diagnosis of Graves’ disease: assessment in a large series of hyperthyroid patients

Razvi Salman , Perros Petros , Parr John , Wahid Shahid

Context: Hyperthyroidism is a common endocrine condition that can be associated with significant morbidity. It is important to ascertain the underlying cause of hyperthyroidism as the natural history, potential complications and response to treatment can be very different.Objective: To investigate if measurement of TSH-receptor binding inhibitory immunoglobulin (TBII), a TSH-receptor antibody found in Graves disease, in the serum of newly diagnosed hyper...

ea0013p341 | Thyroid | SFEBES2007

The relationship between serum TSH levels and blood pressure in a population sample with normal thyroid function

Razvi Salman , French Joyce , Weaver Jolanta , Vanderpump Mark , Pearce Simon

Background: There is evidence to suggest an association between hypothyroidism (overt and subclinical) and cardiovascular disease. It is unclear whether the set-point of the thyroid axis, within the normal range, may be related to vascular risk.Methods: We have reanalysed the data from the original Whickham study to assess BP in the entire cohort and its relationship to serum TSH within the reference range (0.3–6.0 mIU/L). Multivariate stepwise line...